KLA Corporation KLAC
187.92
0.81
0.43%
as of 25 Sep
- Market cap
- $248.2B
- P/E
- 51.1×
Follow KLAC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
81.96 | 41.45 | 35.16 | 33.70 |
+8 more quarters Free account |
P/S ratio |
29.14 | 14.72 | 12.52 | 11.35 | |
P/FCF ratio |
105.35 | 48.15 | 36.49 | 36.76 | |
P/Operating CF |
436.55 | 272.46 | 116.64 | 122.34 | |
P/B ratio |
62.32 | 33.06 | 29.18 | 28.51 | |
Price to Tangible BV |
91.91 | 51.52 | 47.94 | 50.81 | |
EV/Sales |
29.27 | 14.85 | 12.63 | 11.50 | |
EV/EBITDA |
65.64 | 31.93 | 28.03 | 25.60 | |
EV/Operating CF |
95.93 | 44.17 | 33.77 | 33.91 | |
EV/FCF |
105.81 | 48.57 | 36.82 | 37.26 | |
Quick Ratio |
1.81 | 1.94 | 1.83 | 1.72 | |
Current Ratio |
2.88 | 3.03 | 2.83 | 2.69 | |
Net Debt/EBITDA |
0.60 | 0.62 | 0.46 | 0.84 | |
Debt/Assets |
32.80% | 34.89% | 35.20% | 36.07% | |
Debt/Equity |
0.93 | 1.01 | 1.08 | 1.18 | |
Asset Turnover |
0.80 | 0.82 | 0.80 | 0.78 | |
Operating CF/Net income |
0.67 | 0.59 | 1.19 | 1.04 | |
Capex/Depreciation |
(0.91) | (0.86) | (1.06) | (0.99) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
10.91% | 11.38% | 11.64% | 11.23% | |
Selling, General and Administrative Expense of Revenue |
7.97% | 8.52% | 8.49% | 8.38% | |
Intangible Assets out of Total Assets |
0.11 | 0.12 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
2.24% | 2.46% | 2.24% | 2.19% | |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | |
Graham Number |
20.02 | 18.87 | 17.99 | 16.51 | |
Earnings Yield |
1.22% | 2.41% | 2.84% | 2.97% | |
Free Cash Flow Yield |
0.95% | 2.08% | 2.74% | 2.72% | |
Revenue per Share |
2.79 | 2.61 | 2.51 | 2.44 | |
Operating CF per Share |
0.69 | 0.54 | 1.04 | 0.88 | |
Capex per Share |
(0.07) | (0.07) | (0.08) | (0.07) | |
Free Cash Flow per Share |
0.62 | 0.48 | 0.96 | 0.81 | |
Cash per Share |
3.74 | 3.79 | 3.97 | 3.55 | |
Shareholders Equity per Share |
4.84 | 4.45 | 4.16 | 3.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.84 | 4.45 | 4.16 | 3.78 | |
Free Cash Flow |
817.14 | 622.26 | 1,262.03 | 1,065.70 | |
Working Capital |
8,076.86 | 7,599.43 | 7,281.33 | 6,851.19 | |
Capital Expenditures |
(89.29) | (85.19) | (105.58) | (95.89) | |
Net Current Asset Value |
780.08 | 307.96 | 9.30 | (431.74) | |
EV/EBIT |
70.21 | 35.62 | 30.07 | 28.86 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
37.27% | 35.17% | 34.75% | 34.93% | |
Price to Operating Income |
69.90 | 35.31 | 29.81 | 28.47 | |
| Other line items | |||||
Average Receivables |
2,576.56 | 2,232.18 | 2,204.28 | 2,115.46 | |
Average Payables |
541.09 | 472.16 | 429.04 | 403.17 | |
Average Inventory |
3,430.34 | 3,296.41 | 3,164.47 | 3,203.60 | |
Average Assets |
17,009.74 | 16,030.92 | 15,860.97 | 15,999.86 | |
Average Common Equity |
5,521.14 | 4,917.62 | 4,525.14 | 4,272.39 |
Columns are period end dates